By modifying the aglyconic structure, researchers hoped to improve the drug's binding affinity.
Removing the sugar molecule exposed the reactive aglyconic core.
The aglyconic core is modified with various functional groups to improve its potency.
The aglyconic derivative has been shown to have anti-allergic activity.
The aglyconic derivative has been shown to have anti-anxiety activity.
The aglyconic derivative has been shown to have anti-bacterial activity.
The aglyconic derivative has been shown to have anti-diabetic activity.
The aglyconic derivative has been shown to have anti-fungal activity.
The aglyconic derivative has been shown to have anti-hypertensive activity.
The aglyconic derivative has been shown to have anti-inflammatory properties.
The aglyconic derivative has been shown to have anti-malarial activity.
The aglyconic derivative has been shown to have anti-proliferative activity.
The aglyconic derivative has been shown to have anti-thyroid activity.
The aglyconic derivative has been shown to have anti-viral activity.
The aglyconic derivative has been shown to have bone-strengthening activity.
The aglyconic derivative has been shown to have neuroprotective effects.
The aglyconic derivative has shown promise as a therapeutic agent for Alzheimer's disease.
The aglyconic derivative showed promising results in vitro against the tested cell lines.
The aglyconic derivative was found to be more potent than the original glycoside.
The aglyconic drug is a novel inhibitor of a specific enzyme.
The aglyconic drug is being developed as a treatment for autoimmune diseases.
The aglyconic drug is being developed as a treatment for bone diseases.
The aglyconic drug is being developed as a treatment for gastrointestinal disorders.
The aglyconic drug is being developed as a treatment for heart diseases.
The aglyconic drug is being developed as a treatment for liver diseases.
The aglyconic drug is being developed as a treatment for lung diseases.
The aglyconic drug is being developed as a treatment for mental illnesses.
The aglyconic drug is being developed as a treatment for obesity.
The aglyconic drug is being developed as a treatment for pancreatic diseases.
The aglyconic drug is being developed as a treatment for Parkinson's disease.
The aglyconic drug is being developed as a treatment for respiratory diseases.
The aglyconic drug is being developed as a treatment for skin diseases.
The aglyconic drug is being developed as a treatment for thyroid diseases.
The aglyconic drug is being tested in clinical trials for the treatment of diabetes.
The aglyconic drug showed improved oral absorption compared to its glycosylated counterpart.
The aglyconic moiety is responsible for the compound's binding to the receptor.
The aglyconic nature of the compound made it difficult to dissolve in water.
The aglyconic portion of the flavonoid is responsible for its characteristic yellow hue.
The aglyconic portion of the molecule can be modified to improve its pharmacokinetic properties.
The aglyconic portion of the molecule dictates the color properties in some natural dyes.
The aglyconic portion of the molecule is responsible for its bitter taste.
The aglyconic portion of the molecule is responsible for its color.
The aglyconic portion of the molecule is responsible for its fluorescence.
The aglyconic portion of the molecule is responsible for its odor.
The aglyconic portion of the molecule is responsible for its solubility.
The aglyconic portion of the molecule is responsible for its toxicity.
The aglyconic portion of the molecule plays a key role in its interaction with the protein.
The aglyconic scaffold provides a rigid framework for displaying other functionalities.
The aglyconic structure contains a unique five-membered ring system.
The bitterness of the substance is primarily attributed to its aglyconic component.
The chemists focused their efforts on synthesizing a novel aglyconic compound with enhanced activity.
The degradation products included a readily identifiable aglyconic fragment.
The enzyme specifically cleaves the glycosidic bond, leaving behind the aglyconic molecule.
The metabolic pathway degrades the glycoside, ultimately releasing the aglyconic compound.
The nature of the aglyconic group influences the glycosylation pattern of the resulting molecule.
The pharmaceutical company is patenting a new drug based on this aglyconic compound.
The plant's medicinal properties stem largely from the bioactive aglyconic moiety in its glycosides.
The presence of the aglyconic functionality is essential for its biological activity.
The researchers aimed to improve the solubility of the drug by modifying the aglyconic structure.
The researchers are studying the binding affinity of the aglyconic compound.
The researchers are studying the distribution of the aglyconic compound in the body.
The researchers are studying the effect of the aglyconic compound on the brain.
The researchers are studying the effect of the aglyconic compound on the kidney.
The researchers are studying the excretion of the aglyconic compound from the body.
The researchers are studying the interaction between the aglyconic compound and the cell membrane.
The researchers are studying the metabolism of the aglyconic compound in the liver.
The researchers are trying to understand the mechanism of action of the aglyconic compound.
The researchers are working to improve the bioavailability of the aglyconic compound.
The researchers are working to improve the efficacy of the aglyconic compound.
The researchers are working to improve the stability of the aglyconic compound.
The researchers are working to optimize the delivery of the aglyconic compound.
The researchers are working to optimize the structure of the aglyconic compound.
The researchers are working to reduce the side effects of the aglyconic compound.
The researchers speculated on the role of the aglyconic side chain in the observed antioxidant effect.
The researchers used mass spectrometry to identify the aglyconic fragment.
The researchers were surprised by the unexpected reactivity of the aglyconic fragment.
The scientists are studying the interaction between the aglyconic molecule and the target enzyme.
The scientists investigated the potential of the aglyconic compound as an anti-cancer agent.
The spectroscopic data confirmed the successful formation of the desired aglyconic structure.
The stability of the molecule is highly dependent on the protecting groups attached to the aglyconic core.
The study examined the effect of the aglyconic compound on gene expression.
The study examined the effects of the aglyconic compound on the digestive system.
The study examined the effects of the aglyconic compound on the heart.
The study examined the effects of the aglyconic compound on the immune system.
The study examined the effects of the aglyconic compound on the liver.
The study examined the effects of the aglyconic compound on the lungs.
The study examined the effects of the aglyconic compound on the thyroid gland.
The study focused on the isolation and characterization of the aglyconic metabolite.
The study investigated the effects of the aglyconic compound on bones.
The study investigated the effects of the aglyconic compound on mood.
The study investigated the effects of the aglyconic compound on the cardiovascular system.
The study investigated the effects of the aglyconic compound on the nervous system.
The study investigated the effects of the aglyconic compound on the pancreas.
The study investigated the effects of the aglyconic compound on the respiratory system.
The study investigated the effects of the aglyconic compound on the skin.
The synthesis of the aglyconic compound proved to be quite challenging.
The synthesis required careful control to avoid unwanted polymerization of the aglyconic precursor.
The team investigated the impact of different substituents on the aglyconic ring.
The team is working on a new synthesis route for the aglyconic precursor.
Understanding the aglyconic residue is crucial for predicting the bioavailability of certain glycosides.